Literature DB >> 18586866

Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype.

J-P Taylor1, E N Rowan, D Lett, J T O'Brien, I G McKeith, D J Burn.   

Abstract

BACKGROUND: Postural instability gait difficulty (PIGD) motor phenotype in Parkinson's disease (PD) is associated with a faster rate of cognitive decline than in tremor dominant cases and may be a risk factor for incident dementia. People with PD display attentional deficits; however, it is not clear whether attentional deficits in patients with non-demented PD are associated with (i) PIGD phenotype and/or (ii) subsequent cognitive decline. AIMS: (i) To examine rates of cognitive decline (Mini-Mental State Examination (MMSE) and Cambridge Cognitive Examination (CAMCOG)) over 3 years in subjects with non-demented PD aged over 65 years, (ii) using Cognitive Drug Research computerised assessment test battery, determine the rate of change in power of attention (PoA) scores over time (sum of mean choice reaction time, simple reaction time and digit vigilance reaction time scores), (iii) determine whether the PIGD phenotype is associated with changes in PoA and (iv) establish whether baseline PoA is associated with subsequent cognitive decline.
RESULTS: 14 subjects (38%) were classified as PIGD motor phenotype at baseline. Cognitive decline was greater in PIGD compared with non-PIGD subjects (p < or = 0.02). PIGD phenotype was not associated with baseline PoA score although it was associated with subsequent worsening in PoA (mean PoA increase/year: non-PIGD subjects 11.4 ms; PIGD subjects 244.0 ms; p = 0.01). Higher baseline PoA scores were associated with greater cognitive decline (MMSE, p = 0.03; CAMCOG, p = 0.05) independent of PIGD status.
CONCLUSION: PIGD phenotype and attention deficits are independently associated with a greater rate of cognitive decline in patients with non-demented PD. We propose that subtle attentional deficits in patients with non-demented PD predict subsequent cognitive impairment.

Entities:  

Mesh:

Year:  2008        PMID: 18586866     DOI: 10.1136/jnnp.2008.147629

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  Relation of Parkinson's disease subtypes to visual activities of daily living.

Authors:  Daniel R Seichepine; Sandy Neargarder; Ivy N Miller; Tatiana M Riedel; Grover C Gilmore; Alice Cronin-Golomb
Journal:  J Int Neuropsychol Soc       Date:  2011-08-04       Impact factor: 2.892

Review 2.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

3.  Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.

Authors:  Roy N Alcalay; Helen Mejia-Santana; Anat Mirelman; Rachel Saunders-Pullman; Deborah Raymond; Christina Palmese; Elise Caccappolo; Laurie Ozelius; Avi Orr-Urtreger; Lorraine Clark; Nir Giladi; Susan Bressman; Karen Marder
Journal:  Parkinsonism Relat Disord       Date:  2014-11-20       Impact factor: 4.891

Review 4.  The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.

Authors:  John V Hindle
Journal:  J Neural Transm (Vienna)       Date:  2013-02-22       Impact factor: 3.575

5.  Side and type of initial motor symptom influences visuospatial functioning in Parkinson's disease.

Authors:  Daniel R Seichepine; Sandy Neargarder; Sigurros Davidsdottir; Gretchen O Reynolds; Alice Cronin-Golomb
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

6.  Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study.

Authors:  L Arie; Talia Herman; S Shema-Shiratzky; N Giladi; J M Hausdorff
Journal:  J Neurol       Date:  2017-09-06       Impact factor: 4.849

7.  Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Jia Y Wan; Thomas J Montine; Joseph F Quinn; Ignacio F Mata; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; James B Leverenz; Karen L Edwards
Journal:  Mov Disord       Date:  2014-04-07       Impact factor: 10.338

8.  Cognitive function and other non-motor features in non-demented Parkinson's disease motor subtypes.

Authors:  Talia Herman; Aner Weiss; Marina Brozgol; Adi Wilf-Yarkoni; Nir Giladi; Jeffrey M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2014-12-10       Impact factor: 3.575

9.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

10.  Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease.

Authors:  Xiao Deng; Bin Xiao; Hui-Hua Li; Yew-Long Lo; Lai-Mun Chew; Kumar M Prakash; Eng-King Tan
Journal:  J Neurol       Date:  2015-07-26       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.